Beclometasone and Formoterol are combined to treat asthma and chronic obstructive pulmonary disease (COPD). Beclometasone is a corticosteroid that reduces inflammation by blocking chemical messengers responsible for allergic reactions and airway swelling. Formoterol is a long-acting bronchodilator that relaxes airway muscles and widens the air passages, making breathing easier and improving lung function.